171 related articles for article (PubMed ID: 35255889)
1. Alternative medicine: therapeutic effects on gastric original signet ring carcinoma via ascorbate and combination with sodium alpha lipoate.
Chen W; Xu L; Chang E; Gowrishankar G; Ferrara KW; Gambhir SS
BMC Complement Med Ther; 2022 Mar; 22(1):58. PubMed ID: 35255889
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.
Murakami H; Nakanishi H; Tanaka H; Ito S; Misawa K; Ito Y; Ikehara Y; Kondo E; Kodera Y
Gastric Cancer; 2013 Jan; 16(1):74-83. PubMed ID: 22450770
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Profiling of Gastric Signet Ring Cell Carcinoma Tissues Reveals Characteristic Changes of the Complement Cascade Pathway.
Fan Y; Bai B; Liang Y; Ren Y; Liu Y; Zhou F; Lou X; Zi J; Hou G; Chen F; Zhao Q; Liu S
Mol Cell Proteomics; 2021; 20():100068. PubMed ID: 33676000
[TBL] [Abstract][Full Text] [Related]
4. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
[TBL] [Abstract][Full Text] [Related]
5. Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma.
Moon KC; Cho SY; Lee HS; Jeon YK; Chung JH; Jung KC; Chung DH
Arch Pathol Lab Med; 2006 Sep; 130(9):1320-5. PubMed ID: 16948518
[TBL] [Abstract][Full Text] [Related]
6. Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study.
Gertsen EC; van der Veen A; Brenkman HJF; Brosens LAA; van der Post RS; Verhoeven RHA; Luijten JCHBM; Vissers PAJ; Vegt E; van Hillegersberg R; Siersema PD; Ruurda JP
Ann Surg Oncol; 2024 Mar; 31(3):1760-1772. PubMed ID: 38127213
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
Yamaguchi K; Yoshihiro T; Ariyama H; Ito M; Nakano M; Semba Y; Nogami J; Tsuchihashi K; Yamauchi T; Ueno S; Isobe T; Shindo K; Moriyama T; Ohuchida K; Nakamura M; Nagao Y; Ikeda T; Hashizume M; Konomi H; Torisu T; Kitazono T; Kanayama T; Tomita H; Oda Y; Kusaba H; Maeda T; Akashi K; Baba E
Gastric Cancer; 2022 Sep; 25(5):862-878. PubMed ID: 35661943
[TBL] [Abstract][Full Text] [Related]
8. Primary signet-ring cell carcinoma of the lung: histochemical and immunohistochemical characterization.
Hayashi H; Kitamura H; Nakatani Y; Inayama Y; Ito T; Kitamura H
Hum Pathol; 1999 Apr; 30(4):378-83. PubMed ID: 10208457
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma.
Sentani K; Oue N; Tashiro T; Sakamoto N; Nishisaka T; Fukuhara T; Taniyama K; Matsuura H; Arihiro K; Ochiai A; Yasui W
Am J Surg Pathol; 2008 Aug; 32(8):1182-9. PubMed ID: 18580680
[TBL] [Abstract][Full Text] [Related]
10. Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis-Deepening Heterogeneity for a Personalized Therapy.
Ravegnini G; Fosso B; Saverio VD; Sammarini G; Zanotti F; Rossi G; Ricci M; D'Amico F; Valori G; Ioli A; Turroni S; Brigidi P; Hrelia P; Angelini S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419357
[TBL] [Abstract][Full Text] [Related]
11. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J
Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach.
Bozkaya Y; Erdem GU; Ozdemir NY; Demirci NS; Hocazade C; Yazıcı O; Zengin N
Curr Med Res Opin; 2017 Jan; 33(1):109-116. PubMed ID: 27646639
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ
Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):613-21. PubMed ID: 23573307
[TBL] [Abstract][Full Text] [Related]
16. Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study.
Lam R; Tarangelo N; Wang R; Horibe M; Grimshaw AA; Jain D; Haffar S; Bazerbachi F; Kunz PL; Li DK
Oncologist; 2022 Sep; 27(9):751-759. PubMed ID: 35589098
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study.
Pernot S; Dubreuil O; Aparicio T; Le Malicot K; Tougeron D; Lepère C; Lecaille C; Marthey L; Palle J; Bachet JB; Zaanan A; Taieb J
Br J Cancer; 2018 Aug; 119(4):424-428. PubMed ID: 29872148
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the research of gastric signet ring cell carcinoma].
Xu Z; Jin Y; Fang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1196-1200. PubMed ID: 30370520
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):630-8. PubMed ID: 23573309
[TBL] [Abstract][Full Text] [Related]
20. Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features.
Zhao W; Jia Y; Sun G; Yang H; Liu L; Qu X; Ding J; Yu H; Xu B; Zhao S; Xing L; Chai J
Nat Commun; 2023 May; 14(1):2985. PubMed ID: 37225691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]